Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition
Sep 21 2023
•
By
Joseph Haas
BI's R&D strategy centers on novel targets and breakthrough therapies for unmet needs • Source: Boehringer Ingelheim
(dieth+schröder-fotografie)
Candid conversations with C-suite leaders.
Keep up with strategy, innovation and evolving trends across life science industries.
More from Business Strategy
More from In Vivo